BioNTech to develop a mRNA-based malaria vaccine
27th July 2021 Uncategorised 0Clinical trial for first vaccine candidate is planned for the end of 2022
More: BioNTech to develop a mRNA-based malaria vaccine
Source: News
Clinical trial for first vaccine candidate is planned for the end of 2022
More: BioNTech to develop a mRNA-based malaria vaccine
Source: News
© 1994 - 2025 B.M. Pharmaceuticals